Erdogan Batman

436 total citations
8 papers, 201 citations indexed

About

Erdogan Batman is a scholar working on Genetics, Pharmacology and Oncology. According to data from OpenAlex, Erdogan Batman has authored 8 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Pharmacology and 3 papers in Oncology. Recurrent topics in Erdogan Batman's work include Estrogen and related hormone effects (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Erdogan Batman is often cited by papers focused on Estrogen and related hormone effects (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). Erdogan Batman collaborates with scholars based in Netherlands, Belgium and United States. Erdogan Batman's co-authors include Hans Gelderblom, Henk‐Jan Guchelaar, Vincent O. Dezentjé, Carolien H. Smorenburg, Lynn Jongen, Jesse J. Swen, Ton J. Rabelink, Maartje Los, Neeltje Steeghs and Eelco J.P. de Koning and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Erdogan Batman

8 papers receiving 196 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erdogan Batman Netherlands 6 88 86 60 37 37 8 201
Clark Williard United States 8 118 1.3× 68 0.8× 30 0.5× 48 1.3× 44 1.2× 11 270
Jan B. Ruit Netherlands 5 23 0.3× 145 1.7× 20 0.3× 67 1.8× 38 1.0× 6 204
Bryony Eccles United Kingdom 8 115 1.3× 236 2.7× 44 0.7× 61 1.6× 174 4.7× 11 363
Longli Kang China 12 43 0.5× 91 1.1× 105 1.8× 141 3.8× 61 1.6× 36 347
Mirjam de With Netherlands 8 24 0.3× 88 1.0× 53 0.9× 71 1.9× 20 0.5× 13 186
Erika Bågeman Sweden 8 66 0.8× 129 1.5× 40 0.7× 64 1.7× 47 1.3× 14 286
Anne‐Joy M. de Graan Netherlands 12 64 0.7× 282 3.3× 154 2.6× 74 2.0× 28 0.8× 16 425
Dion Chen United States 8 51 0.6× 35 0.4× 43 0.7× 52 1.4× 10 0.3× 9 357
Anton Buchner Germany 12 170 1.9× 230 2.7× 21 0.3× 23 0.6× 12 0.3× 29 380
Bolot Kalmyrzaev United Kingdom 7 148 1.7× 43 0.5× 63 1.1× 74 2.0× 25 0.7× 10 272

Countries citing papers authored by Erdogan Batman

Since Specialization
Citations

This map shows the geographic impact of Erdogan Batman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erdogan Batman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erdogan Batman more than expected).

Fields of papers citing papers by Erdogan Batman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erdogan Batman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erdogan Batman. The network helps show where Erdogan Batman may publish in the future.

Co-authorship network of co-authors of Erdogan Batman

This figure shows the co-authorship network connecting the top 25 collaborators of Erdogan Batman. A scholar is included among the top collaborators of Erdogan Batman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erdogan Batman. Erdogan Batman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Dezentjé, Vincent O., Jesse J. Swen, Dirk Jan A. R. Moes, et al.. (2019). Tamoxifen Pharmacogenetics and Metabolism: Results From the Prospective CYPTAM Study. Journal of Clinical Oncology. 37(8). 636–646. 64 indexed citations
2.
Groot, Stefanie de, Leoni A. Louwé, Johanneke E.A. Portielje, et al.. (2018). Effects of controlled ovarian stimulation on toxicity of TAC chemotherapy in early breast cancer patients. Cancer Management and Research. Volume 10. 3931–3935. 1 indexed citations
3.
Dezentjé, Vincent O., Jesse J. Swen, Dirk Jan A. R. Moes, et al.. (2018). A prospective study on the effect of endoxifen concentration and CYP2D6 phenotypes on clinical outcome in early stage breast cancer patients receiving adjuvant tamoxifen.. Journal of Clinical Oncology. 36(15_suppl). 523–523. 3 indexed citations
4.
Baas, Jara M., Monique M.E.M. Bos, Johanneke E.A. Portielje, et al.. (2015). Safety and efficacy of the addition of simvastatin to panitumumab in previously treated KRAS mutant metastatic colorectal cancer patients. Anti-Cancer Drugs. 26(8). 872–877. 17 indexed citations
5.
Aarts, Maureen J.B., Frank Peters, Caroline M.P.W. Mandigers, et al.. (2013). Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia. Journal of Clinical Oncology. 31(34). 4290–4296. 38 indexed citations
6.
Opdam, Frans L., Vincent O. Dezentjé, Jan den Hartigh, et al.. (2012). The use of the 13C-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels. Cancer Chemotherapy and Pharmacology. 71(3). 593–601. 23 indexed citations
7.
Steeghs, Neeltje, Ton J. Rabelink, Jos Op ’t Roodt, et al.. (2009). Reversibility of capillary density after discontinuation of bevacizumab treatment. Annals of Oncology. 21(5). 1100–1105. 36 indexed citations
8.
Aktaş, Mustafa Sinan, Diederick De Jong, Joost J. Nuyttens, et al.. (2006). Concomitant radiotherapy and hyperthermia for primary carcinoma of the vagina: A cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 133(1). 100–104. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clark Williard Breakdown of academic impact, for papers by Jan B. Ruit Breakdown of academic impact, for papers by Bryony Eccles Breakdown of academic impact, for papers by Longli Kang Breakdown of academic impact, for papers by Mirjam de With Breakdown of academic impact, for papers by Erika Bågeman Breakdown of academic impact, for papers by Anne‐Joy M. de Graan Breakdown of academic impact, for papers by Dion Chen Breakdown of academic impact, for papers by Anton Buchner Breakdown of academic impact, for papers by Bolot Kalmyrzaev
Rankless by CCL
2026